Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 1763292, 10 pages
https://doi.org/10.1155/2017/1763292
Research Article

Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice

1Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
2Neural Injury Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
3Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Correspondence should be addressed to Young Hee Yoon; rk.luoes.cma@nooyhy

Received 7 October 2016; Accepted 30 November 2016; Published 3 January 2017

Academic Editor: Steven F. Abcouwer

Copyright © 2017 Yoo-Ri Chung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Praidou, S. Androudi, P. Brazitikos, G. Karakiulakis, E. Papakonstantinou, and S. Dimitrakos, “Angiogenic growth factors and their inhibitors in diabetic retinopathy,” Current Diabetes Reviews, vol. 6, no. 5, pp. 304–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. L. M. Ruta, D. J. Magliano, R. Lemesurier, H. R. Taylor, P. Z. Zimmet, and J. E. Shaw, “Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries,” Diabetic medicine, vol. 30, no. 4, pp. 387–398, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Bandello, R. Lattanzio, I. Zucchiatti, and C. Del Turco, “Pathophysiology and treatment of diabetic retinopathy,” Acta Diabetologica, vol. 50, no. 1, pp. 1–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. J. H. Eisma, J. E. Dulle, and P. E. Fort, “Current knowledge on diabetic retinopathy from human donor tissues,” World Journal of Diabetes, vol. 6, no. 2, pp. 312–320, 2015. View at Publisher · View at Google Scholar
  5. J. Chhablani, A. Sharma, A. Goud et al., “Neurodegeneration in type 2 diabetes: evidence from spectral-domain optical coherence tomography,” Investigative Ophthalmology & Visual Science, vol. 56, no. 11, pp. 6333–6338, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. Q. Yang, Y. Xu, P. Xie et al., “Retinal neurodegeneration in db/db mice at the early period of diabetes,” Journal of Ophthalmology, vol. 2015, Article ID 757412, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Tang and T. S. Kern, “Inflammation in diabetic retinopathy,” Progress in Retinal and Eye Research, vol. 30, no. 5, pp. 343–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Fu, M. Wu, J. Zhang et al., “Mechanisms of modified LDL-Induced pericyte loss and retinal injury in diabetic retinopathy,” Diabetologia, vol. 55, no. 11, pp. 3128–3140, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. H.-P. Hammes, “Pericytes and the pathogenesis of diabetic retinopathy,” Hormone and Metabolic Research, vol. 37, supplement 1, pp. S39–S43, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Ejaz, “Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy,” Diabetes, Obesity & Metabolism, vol. 10, no. 1, pp. 53–63, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Pfister, Y. Feng, F. V. Hagen et al., “Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy,” Diabetes, vol. 57, no. 9, pp. 2495–2502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Klaassen, C. J. F. Van Noorden, and R. O. Schlingemann, “Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions,” Progress in Retinal and Eye Research, vol. 34, pp. 19–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. S. X. Zhang, J. J. Wang, A. Dashti et al., “Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein,” Journal of Molecular Endocrinology, vol. 41, no. 3-4, pp. 135–143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Renier, J.-C. Mamputu, A.-C. Desfaits, and O. Serri, “Monocyte adhesion in diabetic angiopathy: effects of free-radical scavenging,” Journal of Diabetes and its Complications, vol. 17, no. 2, pp. 20–29, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Sonoki, M. Yoshinari, M. Iwase et al., “Glycoxidized low-density lipoprotein enhances monocyte chemoattractant protein-1 mRNA expression in human umbilical vein endothelial cells: relation to lysophosphatidylcholine contents and inhibition by nitric oxide donor,” Metabolism: Clinical and Experimental, vol. 51, no. 9, pp. 1135–1142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Fu, J. Y. Yu, M. Wu et al., “Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes,” Journal of Lipid Research, vol. 55, no. 5, pp. 860–869, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Motiejunaite and A. Kazlauskas, “Pericytes and ocular diseases,” Experimental Eye Research, vol. 86, no. 2, pp. 171–177, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Li, J. J. Wang, Q. Yu, M. Wang, and S. X. Zhang, “Endoplasmic reticulum stress is implicated in retinal inflammation and diabetic retinopathy,” FEBS Letters, vol. 583, no. 9, pp. 1521–1527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Oshitari, N. Hata, and S. Yamamoto, “Endoplasmic reticulum stress and diabetic retinopathy,” Vascular Health and Risk Management, vol. 4, no. 1, pp. 115–122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Jing, J. J. Wang, and S. X. Zhang, “ER stress and apoptosis: a new mechanism for retinal cell death,” Experimental Diabetes Research, vol. 2012, Article ID 589589, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. S. S. Smith, “Mechanisms of ER stress in retinal diseases,” in Retina, S. J. Ryan, A. P. Schachat, C. P. Wilkinson, D. R. Hinton, S. R. Sadda, and P. Wiedemann, Eds., pp. 529–536, Saunders, London, UK, 5th edition, 2013. View at Google Scholar
  22. S. X. Zhang, E. Sanders, and J. J. Wang, “Endoplasmic reticulum stress and inflammation: mechanisms and implications in diabetic retinopathy,” Journal of Ocular Biology, Diseases, and Informatics, vol. 4, no. 1-2, pp. 51–61, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Ikesugi, M. L. Mulhern, C. J. Madson et al., “Induction of endoplasmic reticulum stress in retinal pericytes by glucose deprivation,” Current Eye Research, vol. 31, no. 11, pp. 947–953, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Schröder and R. J. Kaufman, “The mammalian unfolded protein response,” Annual Review of Biochemistry, vol. 74, pp. 739–789, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Zhong, J. J. Wang, and S. X. Zhang, “Intermittent but not constant high glucose induces ER stress and inflammation in human retinal pericytes,” Advances in Experimental Medicine and Biology, vol. 723, pp. 285–292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Mantopoulos, Y. Murakami, J. Comander et al., “Tauroursodeoxycholic acid (TUDCA) protects photoreceptors from cell death after experimental retinal detachment,” PLOS ONE, vol. 6, no. 9, Article ID e24245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. M. Gaspar, A. Martins, R. Cruz, C. M. P. Rodrigues, A. F. Ambrósio, and A. R. Santiago, “Tauroursodeoxycholic acid protects retinal neural cells from cell death induced by prolonged exposure to elevated glucose,” Neuroscience, vol. 253, pp. 380–388, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Li, H. S. Wang, G. G. Li, M. J. Zhao, and M. H. Zhao, “The role of endoplasmic reticulum stress in the early stage of diabetic retinopathy,” Acta Diabetologica, vol. 48, no. 2, pp. 103–111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. J. Jenkins, V. Velarde, R. L. Klein et al., “Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells,” Diabetes, vol. 49, no. 12, pp. 2160–2169, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. T. J. Lyons, W. Li, B. Wojciechowski, M. C. Wells-Knecht, K. J. Wells-Knecht, and A. J. Jenkins, “Aminoguanidine and the effects of modified LDL on cultured retinal capillary cells,” Investigative Ophthalmology and Visual Science, vol. 41, no. 5, pp. 1176–1180, 2000. View at Google Scholar · View at Scopus
  31. G. H. Tesch and T. J. Allen, “Rodent models of streptozotocin-induced diabetic nephropathy (methods in renal research),” Nephrology, vol. 12, no. 3, pp. 261–266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. B. L. Furman, “Streptozotocin-induced diabetic models in mice and rats,” in Current Protocols in Pharmacology, chapter 5: Unit 5.47, 2015. View at Publisher · View at Google Scholar
  33. S. J. Woo, J. H. Kim, and H. G. Yu, “Ursodeoxycholic acid and tauroursodeoxycholic acid suppress choroidal neovascularization in a laser-treated rat model,” Journal of Ocular Pharmacology and Therapeutics, vol. 26, no. 3, pp. 223–229, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Cai and J. F. McGinnis, “Diabetic retinopathy: animal models, therapies, and perspectives,” Journal of Diabetes Research, vol. 2016, Article ID 3789217, 9 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. A. K. W. Lai and A. C. Y. Lo, “Animal models of diabetic retinopathy: summary and comparison,” Journal of Diabetes Research, vol. 2013, Article ID 106594, 29 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. J. A. Choi, Anti-ALS drus riluzole attenuates pericyte loss in diabetic retinopathy of streptozotocin-treated mouse [M.S. thesis], University of Ulsan, 2013.
  37. W. Leskova, M. N. Watts, P. R. Carter, R. S. Eshaq, and N. R. Harris, “Measurement of retinal blood flow rate in diabetic rats: disparity between techniques due to redistribution of flow,” Investigative Ophthalmology & Visual Science, vol. 54, no. 4, pp. 2992–2999, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Newbold, B. P. Martin, C. Cullinane, and M. Bots, “Detection of apoptotic cells using propidium iodide staining,” Cold Spring Harbor Protocols, vol. 2014, no. 11, pp. 1202–1206, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Riccardi and I. Nicoletti, “Analysis of apoptosis by propidium iodide staining and flow cytometry,” Nature Protocols, vol. 1, no. 3, pp. 1458–1461, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Y. Chew, M. D. Davis, R. P. Danis et al., “The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study,” Ophthalmology, vol. 121, pp. 2443–2451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Du, M. Wu, D. Fu et al., “Effects of modified LDL and HDL on retinal pigment epithelial cells: a role in diabetic retinopathy?” Diabetologia, vol. 56, no. 10, pp. 2318–2328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. J. W. Y. Yau, S. L. Rogers, R. Kawasaki et al., “Global prevalence and major risk factors of diabetic retinopathy,” Diabetes Care, vol. 35, no. 3, pp. 556–564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. A. W. Stitt, N. Lois, R. J. Medina, P. Adamson, and T. M. Curtis, “Advances in our understanding of diabetic retinopathy,” Clinical Science, vol. 125, no. 1, pp. 1–17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Williams, M. Airey, H. Baxter, J. Forrester, T. Kennedy-Martin, and A. Girach, “Epidemiology of diabetic retinopathy and macular oedema: a systematic review,” Eye, vol. 18, no. 10, pp. 963–983, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Resnikoff, D. Pascolini, D. Etya'ale et al., “Global data on visual impairment in the year 2002,” Bulletin of the World Health Organization, vol. 82, no. 11, pp. 844–851, 2004. View at Google Scholar · View at Scopus
  46. E. Y. Chew, W. T. Ambrosius, M. D. Davis et al., “Effects of medical therapies on retinopathy progression in type 2 diabetes,” The New England Journal of Medicine, vol. 363, no. 3, pp. 233–244, 2010. View at Publisher · View at Google Scholar
  47. The Diabetes Control and Complications Trial, “The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus,” Archives of Ophthalmology, vol. 113, no. 1, pp. 36–51, 1995. View at Publisher · View at Google Scholar
  48. L. P. Aiello, “The potential role of PKC β in diabetic retinopathy and macular edema,” Survey of Ophthalmology, vol. 47, no. 2, pp. S263–S269, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. W.-K. Hu, R. Liu, H. Pei, and B. Li, “Endoplasmic reticulum stress-related factors protect against diabetic retinopathy,” Experimental Diabetes Research, vol. 2012, Article ID 507986, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. E. S. Shin, Q. Huang, Z. Gurel et al., “STAT1-mediated Bim expression promotes the apoptosis of retinal pericytes under high glucose conditions,” Cell Death & Disease, vol. 5, no. 1, article e986, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. T. S. Devi, K.-I. Hosoya, T. Terasaki, and L. P. Singh, “Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: implications for diabetic retinopathy,” Experimental Cell Research, vol. 319, no. 7, pp. 1001–1012, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. B.-H. Chen, D.-Y. Jiang, and L.-S. Tang, “Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes,” Life Sciences, vol. 79, no. 11, pp. 1040–1048, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. U. Özcan, E. Yilmaz, L. Özcan et al., “Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes,” Science, vol. 313, no. 5790, pp. 1137–1140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Wisniewska-Kruk, I. Klaassen, I. M. C. Vogels et al., “Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy,” Experimental Eye Research, vol. 122, pp. 123–131, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. A.-L. Cao, L. Wang, X. Chen et al., “Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy,” Laboratory Investigation, vol. 96, no. 6, pp. 610–622, 2016. View at Publisher · View at Google Scholar